Literature DB >> 12625972

Varicella vaccination during early pregnancy: a cause of in utero miliary fetal tissue calcifications and hydrops?

Joseph Apuzzio1, Vijaya Ganesh, Leslie Iffy, Anthony Al-Khan.   

Abstract

BACKGROUND: It is the purpose of this article to describe a suspected association of inadvertent vaccination with varicella vaccine during early pregnancy with the subsequent development of in utero miliary fetal tissue calcifications and fetal hydrops detected by sonogram at 15 weeks of gestation. CASE: This is a case presentation of a pregnant patient who received varicella vaccination during the same menstrual cycle that she became pregnant, and is supplemented by a literary review. The fetus developed miliary fetal tissue calcifications and fetal hydrops detected by a targeted sonogram at 15 weeks gestation.
CONCLUSION: Varicella vaccination during early pregnancy may be a cause of miliary fetal tissue calcifications and fetal hydrops.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12625972      PMCID: PMC1784611          DOI: 10.1155/S1064744902000169

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  2 in total

Review 1.  Congenital varicella-zoster virus infection after maternal subclinical infection: clinical and neuropathological findings.

Authors:  K Mustonen; P Mustakangas; L Valanne; M H Professor; M Koskiniemi
Journal:  J Perinatol       Date:  2001-03       Impact factor: 2.521

2.  Prenatal diagnosis of congenital varicella syndrome and detection of varicella-zoster virus in the fetus: a case report.

Authors:  J Hartung; G Enders; R Chaoui; A Arents; C Tennstedt; R Bollmann
Journal:  Prenat Diagn       Date:  1999-02       Impact factor: 3.050

  2 in total
  1 in total

Review 1.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.